Lymphoedema is a chronic, progressive condition. There is no cure but it is most easily managed with early recognition and therapy; those who do not have treatment tend to worsen rapidly and advanced disease is more difficult to treat than early disease. Surgery for lymphoedema is often regarded as a last resort but traditional excisional techniques that have been slightly modified for modern practice have shown good results, whilst newer microsurgical reconstruction techniques show promise although
Introduction
Lymphoedema is characterised by an imbalance of lymphatic flow leading to accumulation of proteinrich fluid in the interstitium of subcutaneous tissues. The consequent swelling may cause cosmetic and functional impairment, with significant physical and psychological morbidity. There is progressive damage to the lymphatics with inflammation, fibrosis and more swelling, eventually leading to elephantiasis. Recurrent infection is a common complication whilst lymphangiosarcomas are rare, occurring in 0.03% of patients surviving more than 10 years after mastectomy. 1 It is traditional to classify lymphoedema into primary or secondary forms-in the former there is congenital lymphatic dysfunction related to dysplasia/malformation whilst in the latter there is disruption of lymphatic outflow related to another disease process or due to iatrogenic mechanisms.
Primary lymphoedema
The traditional subdivision of primary lymphoedema according to the time of onset has little clinical significance. There is confusion in the literature regarding the terms used, particularly, the various eponymous syndromes that have been described; most cases of primary lymphoedema are not associated with specific syndromes.
• Congenita (10% of cases): the swelling is often present at birth (any swelling that begins before the age of 2 years is included in this group).
• Praecox (80% of cases): patients present with swelling before the age of 35 years.
• Tarda (10% of cases): patients present after the age of 35 years with swelling that is usually bilateral. Lymphatic vessels tend to be hyperplastic.
It is important to appreciate that primary lymphoedema is a heterogeneous group with many subtypes occurring due to many different causes which are generally poorly understood. The term Milroy's disease is often used interchangeably with lymphoedema congenita-it should only be applied to the group of inherited congenital lymphoedemas that demonstrates autosomal dominant inheritance; it is linked to vascular endothelial growth factor (VEGF) receptor-3 mutations (FLT4 gene on locus 5q35. 3) 2,3 and some evidence reveals that there is a functional defect of absorption rather than a gross structural defect.
Lymphoedema praecox is the commonest type (80% of cases) and the swelling may be unilateral and limited to the foot/calf region. Patients lack distal lymphatics (hypoplasia) and often have a strong family history, some demonstrating autosomal dominant inheritance with different mutations in FOXC2 gene on chromosome 16 . 4 Some patients with praecox have distichiasis (double row of eyelashes) and form a distinct syndromic entitylymphoedema distichiasis (mutation on 16q24.3). 5 Patients with Meige's disease, which is a subset of lymphoedema, usually present at puberty and the term should be reserved for those with the familial form of the disease (with as-yet unknown mutation).
lymphoedema most often follows the treatment of breast cancer, typically after a latent period of variable duration-77% of cases present within 3 years of surgery 7 but the condition can arise at any time.
Although the exact mechanism of the response of lymphatic channels to trauma is unknown, in general, the more extensive the surgery the greater is the damage. Thus, a formal axillary node dissection carries a risk of up to 20% compared to 4% to 10% following sentinel node biopsy. [8] [9] [10] [11] Irradiation causes fibrosis and inhibits lymphangiogenesis and, approximately, doubles the risk of developing lymphoedema after nodal surgery. Lymph vessels do have some regenerative capacity 12 and not all patients undergoing surgery and/or radiotherapy develop lymphoedema; it may be related to some underlying susceptibility that is as yet undefined, and may be, possibly, genetic. 13 Patients with lymphoedema often have subtle lymphatic anomalies in the contralateral limb.
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Staging
The International Society of Lymphology staging is the most commonly used system (Table 1 15 ), but it is somewhat flawed in that it is based only on physical findings. Some experts suggest incorporating measures of quality of life (QOL) to improve its usefulness. 16 The classification offered by Campisi et al 17 shows congruence with indocyanine green (ICG) dermal backflow patterns, which provides an indication of lymphatic function (Table 2) . [17] [18] [19] Bioimpedance spectroscopy uses electric current to measure the degree of tissue fluid retention and is useful in detecting early-stage lymphoedema including stage 0 disease.
The most commonly used method of objectively assessing the swelling is some form of conal measurement, such as measuring the circumference at 4 cm intervals, which is more practical than water displacement methods 20, 21 but is, supposedly, similar in accuracy. 22 A perometer uses infrared rays to measure limb cross-sections at multiple intervals and, thus, determine the volume of the limb. 23 The author has been exploring the idea of using Kinect (part of the Microsoft Xbox game system) as a three-dimensional scanner to gauge volume in collaboration with the Department of Computer Science and Engineering at The Chinese University of Hong Kong.
Imaging
In most cases, diagnosis can be made from the Lymphangiography involves direct cannulation of a lymphatic vessel on the dorsum of the foot or hand (under magnification). An oil-based contrast material is then injected through this vessel and serial plain radiographs of the limb are taken, allowing the lymphatics to be precisely delineated. Due to the potential of damage to the lymphatic vessels, it can theoretically worsen lymphoedema and, thus, is not commonly used.
Radionuclide lymphoscintigraphy is the current standard investigation for evaluation of lymphatic function. Technetium-labelled colloid is injected into the web spaces of the toes or fingers, and drainage of the colloid from the injection site and the time taken to move proximally are recorded using a gamma camera. It is minimally invasive and enables making both qualitative and quantitative analyses. It does not require dye injection, a method that has been occasionally complicated by allergic skin reactions or anaphylaxis.
Magnetic resonance lymphangiography may replace lymphoscintigraphy as it does not require direct injection of contrast and avoids the use of ionising radiation using a magnetic contrast medium to provide a sharp image of lymphatic vessels. In our early experience with this investigation, reproducibility has been a potential issue and needs further evaluation.
Near-infrared fluorescence imaging with ICG is a promising emerging imaging modality that allows dynamic study of even small lymphatics in the skin.
Treatment
There is no cure for lymphoedema but it is easily managed with early recognition and therapy. Those who do not have treatment tend to worsen rapidly and advanced disease tends to be more difficult to treat than early disease. Patients are best treated in a specialised clinic 24 ; inexperienced staff may delay treatment, or worse, advocate inappropriate treatments.
The standard of care for lymphoedema is, what is commonly referred as, complex (or combined or complete) physical therapy (CPT, sometimes called complex decongestive therapy [CDT] ), which is a staged combination of various components in two phases. The actual treatment regimen varies significantly by locality but, in general, 60% to 70% of compliant patients will respond to CPT when administered by specially trained therapists, with an average volume reduction of 50%. 25, 26 However, the time and effort involved, as well as the associated moderate discomfort, lead to decreased patient compliance, particularly in the long term.
(1) Phase 1, also known as the 'decongestive phase' , often requires the patient to be admitted as an in-patient as the regimen is intensive. Treated 5 days a week, it may take 4 to 6 weeks or more to have an effect on the limb volume, depending on the severity of the disease. A lack of effect may be due to improper technique, non-compliance, or incorrect diagnosis.
• Manual lymph drainage (MLD) is not the same as massage; it is a much lighter, slow and specific action that aims to promote lymph movement in the superficial tissues away from the swelling.
• Compression bandage is applied to reduce limb size but the bandages used are not of the standard variety-they are short and non-stretch, and applied with more pressure distally than proximally. This aims to move fluid out of the limb (hence the proximal portions need to be emptied with MLD first). It is only really effective within a CPT programme; the efficacy is reduced considerably in advanced disease.
• Nail/skin care and exercises with bandaging/ pressure garments as tight as tolerated to oppose the filtration pressure and provide counterforce to muscle contractions. Concerns that exercise may exacerbate or trigger lymphoedema have not been proven in studies. (2) Phase 2, or the maintenance phase, can be out-patient-based or as self-care in selected trained patients. Patients should wear pressure garments during the day and compression bandages at night (alternatives include specifically designed garments such as Reid sleeves). Intermittent pneumatic compression machines are sometimes used but care needs to be taken to ensure that they have appropriate design, action, and pressures (usually 30-60 mm Hg though pressures of >45 mm Hg can cause lymphatics to rupture). Pneumatic compression is to be avoided in those with chronic nonpitting disease or those with active infection. Systematic reviews support the use of CDT and MLD. Conservative therapy can give good results but the effects are temporary without the maintenance and continued compression. In Hong Kong, the climate may reduce patient compliance with pressure garments. General care is also important; patients are advised to avoid even minor degrees of trauma such as venepuncture, insect bites, and acupuncture. The evidence for some of the following preventive practices is low but they are simple to follow.
• Air travel: maintain hydration and mobilisation, whilst some experts suggest wearing pressure garments.
• Avoid overuse of the affected limb.
• Avoid trauma; take care when cutting nails, avoid needlestick/venepuncture, and blood pressure measurement. Patients can wear medical alert bracelets to inform others of the condition.
• Avoid extremes of heat/cold and overtight clothing.
Medications such as benzopyrenes and diuretics are not useful and will not be discussed any further. Oral penicillins such as amoxicillin and dicloxacillin should be started early when there is evidence of infection in a lymphoedematous limb and continued until the signs of inflammation resolve. There is borderline support for the use of prophylactic antibiotics in those who have more than two to three episodes of infection a year. Many modalities have been promoted for the non-surgical treatment of lymphoedema but at present only lowlevel laser therapy has approval from the US Food and Drug Administration (FDA), although evidence of its long-term effects is lacking-it generates lowintensity light (650-1000 nm) that is believed to promote lymph vessel regeneration and increase lymph pumping. The typical response is moderate and slow, and requires repeated treatments. Nearinfrared light therapy aims to increase nitric oxide in the tissues to improve tissue repair and lymph regeneration but has not received FDA approval, whilst electrical stimulation is not recommended based on current evidence.
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Surgery
For reasons such as concerns of scarring or perceived lack of effect, surgery has often been regarded as a 'last resort' , meaning that there is often a delay before patients are referred 28 by which time they may only be suited for 'salvage' procedures. Whilst initial attempts at 'physiological' reconstruction were met with disappointing late results, improved understanding of the pathophysiology accompanied by improved microsurgical techniques have seen the development of newer techniques that seem to potentially offer better outcomes.
Physiological/reconstructive techniques
Physiological techniques aim to repair the damage and increase the return of lymph to the circulation, by reconnecting the lymphatic pathways above and beyond the obstruction, either directly (lymphatic to lymphatic) or indirectly via another segment such as veins/venules. Campisi et al 17, 29, 30 have been a pioneer of these microsurgical techniques and classified them into 'derivative' techniques (essentially a lymphovenous bypass) and 'reconstructive' techniques (lymphatic-to-lymphatic connections).
Lymphovenous anastomosis or bypass
When interpreting the literature describing lymphovenous bypass, it is important to note the fundamental difference between early (lymphovenous) and newer (lymphaticovenular) techniques. The bypass concept was first described in 1963 in a rat model 31 whilst Yamada 32 and O'Brien et al 33 were the first to use it in patients. O'Brien et al 33 anastomosed lymphatics to veins measuring approximately 1 to 3 mm diameter and reported an average volume reduction of 44% in this series with 14 years' follow-up. Campisi et al 30 reported an average of 67% reduction in volume and 87% reduction in cellulitis in this large long-term series. Overall, 85% of patients were able to stop conservative management. However, one criticism of these retrospective studies was patient heterogeneity.
However, Damstra et al 34 found no improvement in patients with postmastectomy lymphoedema who were treated with lymphovenous anastomosis/bypass; a prospective study of 10 patients demonstrated only a 4.8% volume reduction at 3 months that was further reduced to 2% after 1 year, with minimal improvement in reported QOL. Boccardo et al 35, 36 performed lymphovenous bypass at the time of breast surgery with the aim of preventing lymphoedema-they anastomosed tributaries of the axillary vein to lymphatics with a patency rate of 95.6% but found no difference in limb volume compared with controls at up to 18 months' follow-up.
Lymphaticovenular anastomoses
In Koshima et al's opinion, [37] [38] [39] there were inherent problems in lymphovenous anastomoses: (1) it is difficult to find larger lymphatic trunks, most are 0.8 mm or under in diameter; (2) reduced lymphatic pumping function; and (3) increased venous pressure and high rate of thrombosis due to blood at anastomotic site. According to these authors, lymphaticovenular anastomosis (LVA) offered better vessel size match compared with lymphovenous anastomoses. In 52 patients with an average of 2.1 LVAs per patient, there was a mean reduction of 41.8% in leg circumference at a mean follow-up of 14.5 months. Benefit could be demonstrated even in patients with stage III/IV disease, with recurrent lymphangitis and fibrosis. Koshima et al [37] [38] [39] have also applied the technique in early disease for prophylaxis against development of fibrotic disease.
The Tokyo group uses ICG fluorescent lymphography to stage the disease severity based on the amount of dermal backflow, and thus, select patients for surgery. 40, 41 Subdermal vessels are explored through small (<3 cm) skin incisions, aiming to use lymphatic vessels of approximately 0.2 mm in diameter with venules sized 0.5 mm or less on the basis that smaller veins will have lower pressures. Some call this 'supermicrosurgery' although the use of the term is rather arbitrary. The procedure can be performed under local anaesthesia with short hospital stay, which, in the author's opinion, is one of the biggest advantages of this technique.
The 
Lymph node transfer
Wongtrungkapun 44 performed lymph node transfer in patients with filariasis; one to two groin nodes were partially decapsulated and anastomosed to the saphenous vein. Becker et al 45, 46 described the transfer of lymph nodes from the groin to the axilla in 24 patients with postmastectomy lymphoedema; 62.5% of the patients were said to be 'cured' and able to discontinue physiotherapy. Overall, in Becker et al's experience, 45, 46 98% of the patients had some improvement; only 2% had repeat infections. Whilst 40% of patients with stage 1 or 2 lymphoedema had complete normalisation and did not require additional conservative therapy, those with stage 3 lymphoedema needed conservative therapy. Lin et al 47 anastomosed superficial circumflex iliac nodes at the wrist to treat upper limb lymphoedema and reported a 55% reduction in volume at 56 months, with fewer episodes of cellulitis.
Proponents of node surgery say that LVA or lymphatic-lymphatic anastomosis eventually become occluded (possibly due to the effect of interstitial pressure on low-pressure thin vessels) whilst lymph nodes are supposedly less susceptible. The lymphatic vessels are not actually anastomosed; it seems that the transplanted nodes develop new drainage pathways-proposed theories for this drainage include nodes acting as suction pumps whilst others suggest they are a source of VEGF-C that promotes lymphangiogenesis.
Some experts have developed a procedure to transfer lymph nodes as part of a breast reconstruction procedure 48 ; there may be several other benefits of such a procedure including release of scar tissue in the axilla and the provision of vascularised tissue as a lymphatic bridge. 49 Isotope scans at 3 and 6 months demonstrated improved function in all but one patient. 48 With this type of surgery, it is important to only harvest nodes of lower abdomen and not the leg; axillary reverse mapping may help to spare limb lymphatics. 50 Overall, good long-term functional data are lacking and some authors have had difficulty reproducing published results, 25 possibly, due to the significant learning curve. Some have found 38% risk of complications, although mostly transient (eg lymphocele and hydrocele); however, some complications such as iatrogenic lymphoedema and chronic pain may be more persistent. 51 They also found no volume difference after a median followup of 40 months with interval CDT and pressure garments. Viitanen et al 52 found reduced lymphatic flow in the donor site/limb with lymphoscintigraphy without overt clinical lymphoedema in a small group of 10 patients.
Preliminary results suggest that node transfer is more successful if performed sooner after nodal dissection surgery. 45, 53 Saaristo et al 48 regard it as largely experimental but can be justified if performed at the time of breast reconstruction. Some surgeons have looked at animal models, combining node transfer with additional VEGF-C and -D, 54, 55 and this may offer a new type of treatment; however, the effect on lymphatic metastasis is unknown and deserves attention.
Lymphatic grafting/ transplantation
Other less commonly used procedures include lymphatic grafting. Baumeister et al [56] [57] [58] [59] have significant experience in using this technique to treat secondary lymphoedema with an average volume reduction of 65%. 60, 61 In the lower limb, a long segment of lymphatic vessel is dissected out from the upper inner thigh and tunnelled over to affected contralateral leg for a lymphatic-lymphatic anastomosis. The efficacy in the upper limb where the lymphatic tissue is used as a free graft has also been demonstrated with significant improvement in over 90% of patients, with a mean volume reduction of 22% to 31% whilst scintigraphy shows continued graft function. [62] [63] [64] The dissection of lymphatics is technically challenging; Campisi 65 used veins instead of lymphatic vessels to bridge lymphatics.
Some experts have used flaps for lymphatic bridging; for instance, the inclusion of random lymphatics in tissues such as the omentum 66 or an axial flap such as the deltopectoral. 67 The use of omentum has largely been abandoned as there is no evidence that it actually promotes lymph drainage, and the surgery is associated with high rates of morbidity. Similarly, enteromesenteric bridge operations and tube/thread implants should be avoided, based on current evidence.
Debulking or excision
Early attempts at treating lymphoedema involved techniques that were mainly based on debulking, that is, removing the oedematous tissue to restore form. The underlying lymphatic dysfunction is not addressed and may actually lead to further deterioration of the condition.
Charles procedure
The Charles procedure used in 1912 has been wrongly attributed to Sir Richard Charles for the treatment of leg lymphoedema by McIndoe. 68 The surgeon had primarily treated scrotal swelling 69 and had only described one unsuccessful case involving the lower limb. In simple terms, the lymphoedematous tissue is excised down to the fascial level and the defect is covered with skin grafts. The grafts can be taken from the excised tissue if it is not grossly abnormal 70 ; otherwise, it has to be harvested from another site. Complications include graft breakdown/ulceration, scarring, and recurrence. The aesthetic results are rather poor and, thus, usually reserved for cases with severe skin changes.
Homans-Miller procedure
The Homans-Miller procedure, first used in 1936, is based on a multistage procedure initially described by Sistrunk 71 -skin flaps are elevated along one border of the limb, and after the deeper swollen tissue has been excised along with the fascia, the skin flaps are replaced. 72, 73 It is a traditional practice to avoid surgery at or below ankle, taking care to avoid damage to the common peroneal and sural nerves. A study with 14 years' follow-up showed that this type of surgery was capable of long-lasting reduction in size in 80% of the treated patients, and associated with improved function and reduced cellulitis. 73 It is the most common excisional surgery for lymphoedema. Others have refined this further by preserving the perforator vessels during flap elevation, allowing the flaps to be thinner (5 mm) and, potentially, for both sides to be treated in one stage. 74 The Thompson technique used in 1962 involves similar tissue resection whilst also harvesting a dermal flap 75 that is buried into the muscle next to the neurovascular bundle, with the aim of creating a bridge for lymphatic return. However, long-term results were similar to excision alone and did not support the theoretical aim of a physiological effect and, thus, has largely been abandoned.
The proven benefits of excisional surgery are often ignored, in part due to misconceptions of morbidity and complications; these were mostly related to early aggressive use of the technique leading to almost total abandonment of procedures in the mid-20th century. Recently Karri et al 76 demonstrated that good results are possible with modern application of the Charles procedure that may also be combined with negative-pressure wound therapy. 77 Similarly, surgeons have modified the Homans-Miller procedure 25 and combined this with postoperative pressure garments to achieve good results.
Liposuction
Liposuction is a relatively recently described debulking technique based on the observation that there is adipose hypertrophy in lymphoedema. The fat accumulation may be related to altered lipid transport 78, 79 and corresponds to a non-pitting type of swelling that is not responsive to compression.
O'Brien et al 80 were one of the first surgeons to use liposuction to treat lymphoedema, and reported a volume reduction of 23%. Brorson et al 81 used liposuction to treat patients with postbreast cancer lymphoedema that had been resistant to conservative therapy with reasonable effects that were confirmed with volume measurements, computed tomographic scans, and plethysmography. Liposuction for lymphoedema is similar but not the same as cosmetic liposuction. The technique has evolved in several ways, particularly, with the adoption of a tumescent technique with injection of adrenaline combined with use of a tourniquet that causes less bleeding-13% versus 25% without tourniquet. 82 More recently, Schaverien et al 83 used the Brorson technique (1997) and demonstrated a 101% reduction compared to normal limb at 1 year, and that was maintained at 5 years.
The technique seems to be straightforward and safe, and produces consistent results [84] [85] [86] with treated patients reporting improved QOL and suffering from decreased episodes of cellulitis. Preliminary results with laser Doppler scanning seem to support the theory that liposuction can reduce the lymphatic load 87 without damaging lymph function. 88 The National Institute for Health and Care Excellence 89 suggests that liposuction may be considered in those patients with severe disease (massive incapacitating disease, unresponsive to conservative therapy). The morbidity may be less than traditional debulking surgeries and, thus, it can be regarded as the first choice of a debulking operation, if the skin is normal. Its main disadvantage is that patients are required to wear lifelong compression garments 90 ; otherwise, the treated limb enlarges again; this may make the modality less suited in regions such as Hong Kong.
Lymphoedema surgery in Hong Kong
Since 1993, breast cancer has become the most common cancer in women in Hong Kong with an incidence of 79.4/100 000 in 2009. 91 A local study presented at the 2010 Hospital Authority Convention found that 11.3% of patients had lymphoedema at 3 months after breast cancer surgery with axillary dissection. 92 Mak et al 93 found that previous infection-inflammation (odds ratio [OR]=4.49), surgery on the side of the dominant hand (OR=2.97), increased body mass index, and older age at the time of axillary dissection were significant risk factors for the development of moderate-to-severe lymphoedema in our local population.
Despite the significant number of patients liable to suffer from breast cancer-related lymphoedema (BCRL), the general awareness of lymphoedema in Hong Kong is low among both health care professionals and patients. It is a common misconception that nothing can be done for the condition; thus, patients tend to be diagnosed late with symptomatic moderate-to-severe disease, and salvage-type surgical procedures are often the only therapeutic option.
Medical costs for women with BCRL are substantially higher than for those without, 94 with the difference mostly accounted for by the costs of treating infections. A local study 95 unit has organised courses in supermicrosurgery and lymph node transfer to encourage the uptake of these techniques among other surgeons. Lymphatic venous anastomosis has been performed in Hong Kong since 2012 (Figs 1 and 2 ) and the preliminary results are encouraging, with patients often describing early relief, particularly from symptoms of 'tightness' . Given the short period of experience and small number of patients, it is too early to comment on local results; however, there is no reason to suggest that the results would not be comparable with international findings in the long term.
